The treating scenario in genitourinary oncology: what is new? Part 1

By Bracarda Sergio   Montironi Rodolfo   Porta Camillo   Szczylic Cezary   Bearz Alessandra   Cartenì Giacomo   Bellmunt Joaquim  

Future Oncology, Vol. 9, Iss. 6, 2013-06 ,pp. : 797-801

Future Medicine

Access to resources Recommend Favorite

Medicare and Prescription Drugs—What Are the Implications of a New Benefit?

By  

The Genesis Report - Rx, Vol. 8, Iss. 4, 1999-06 ,pp. : 37-40

Adis International

Access to resources Recommend Favorite

What factors do cancer patients believe contribute to the development of their cancer? (New South Wales, Australia)

By Willcox Simon  

Cancer Causes and Control, Vol. 22, Iss. 11, 2011-11 ,pp. : 1503-1511

Springer Publishing Company

Access to resources Recommend Favorite

Concordance of HER2 in primary tumor and leptomeningeal metastases: now what?

By Lin Nancy  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 129-131

Springer Publishing Company

Access to resources Recommend Favorite

Staging the mediastinum: what is current best practice?

By Dougherty Brendan   Jersmann Hubertus PA   Robinson Peter C   Nguyen Phan  

Lung Cancer Management, Vol. 2, Iss. 2, 2013-04 ,pp. : 153-162

Future Medicine

Access to resources Recommend Favorite